HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Perurena, O. H. Articles by Festoff, B. W. Search for Related Content PubMed PubMed Citation Articles by Perurena, O. H. Articles by Festoff, B. W.

Reduction in insulin receptors in amyotrophic lateral sclerosis correlates with reduced insulin sensitivity

Neurobiology Research Laboratory (151), Veterans Adminiitration Medical Center, Kansas City, MO; and the Department of Neurology (Drs. Perurena and Festoff), University of Kansas Medical Center, Kansas City, KS.

Abnormal glucose and insulin metabolism have often been reported in patients with amyotrophic lateral sclerosis. Recently, we have demonstrated reduced insulin sensitivity in this disease and suggested that muscle wasting was not the principal determinant of this reduction. In the current studies, insulin binding to circulating mononuclear leukocytes from 10 amyotrophic lateral sclerosis patients and 16 controls were compared. The relative capacity and affinity of monocyte insulin binding sites were estimated, and simultaneous plasma insulin levels were also obtained. A 2¹/₂-fold reduction in the number of binding sites (percent ¹²⁵I-insulin bound to monocytes) was found in the patients compared with controls (p = 0.001). No differences were obtained when ED₅₀ plots (relative affinity) were compared (p = 0.5). Ideal body weight was similar in both groups (approximately 100%) and plasma insulin levels were not elevated in the patients, suggesting that "down-regulation" from increased ambient hormone levels was not a factor in the lowered receptor numbers. A definite correlation was not found when numbers of insulin receptors were compared with disease progression, body weight, or plasma insulin levels. However, future studies with larger numbers of patients along with quantitation of disease progression may indicate such a trend.

Addrees correspondence and reprint requests to Dr. Festoff, Neurobiology Research Laboratory (151), VA Medical Center, 4801 Linwood Boulevard, Kaneas City, MO 64128.

Supported in part by the Keith Worthington ALS Research Center, the ALS Association, the Arthur and Jane Levien Family Foundation, the Muscular Dystrophy Association, and the Medical Research Service of the Veterans Administration.

Received June 6, 1983. Accepted for publication in final form November 6, 1986.